A Randomized Clinical Trial of Transcatheter Arterial Infusion (TAI) appending to Radio Frequency Ablation Therapy for Hepatocellular Carcinoma
Not Applicable
Recruiting
- Conditions
- Hepatocellular Carcinoma
- Registration Number
- JPRN-UMIN000008253
- Lead Sponsor
- Kyoundo Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Not provided
Exclusion Criteria
1)Severe complications excluding cirrhosis. 2)Active other cancers. 3)History of severe allergy. 4)Pregnant or maybe pregnant, breast-feeding. 5)A case have plan to use interferon during this study period.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method recurrence-free survival, recurrence rate(local, distant)
- Secondary Outcome Measures
Name Time Method